Inventor · disambiguated record
Mike Rothe
Also filed as: ROTHE MIKE
46 granted patents·5 pending applications·457 citations·filing 1994–2022
98Inventor score
Top patents by PatentIndex Score
51 records- 0196US7705130B2Antibodies directed to HER-3 and uses thereofU3 PHARMA GMBH·Filed 2007·Granted Apr 27, 2010·84 cites·29 claims
- 0290US6187557B1c-IAP1 and c-IAP2: inhibitors of apoptosisTULARIK INC·Filed 1995·Granted Feb 13, 2001·75 cites·17 claims
- 0385US8771695B2Antibodies directed to HER-3 and uses thereofROTHE MIKE·Filed 2010·Granted Jul 8, 2014·8 cites·20 claims
- 0483US10081676B2Human anti-IL-32 antibodies and methods of making and using the sameIMMUNOQURE AG·Filed 2014·Granted Sep 25, 2018·4 cites·35 claims
- 0582US5789550ATRAF inhibitorsGENENTECH INC·Filed 1996·Granted Aug 4, 1998·25 cites·6 claims
- 0681US5854003AScreening method for agents that modulate human NIK activityTULARIK INC·Filed 1998·Granted Dec 29, 1998·44 cites·9 claims
- 0779US10112995B2Human anti-IFN-α antibodiesIMMUNOQURE AG·Filed 2014·Granted Oct 30, 2018·4 cites·34 claims
- 0879US2023059353A1Antibodies directed to her-3 and uses thereofDAIICHI SANKYO EUROPE GMBH·Filed 2022·Application pending·0 cites
- 0978US9988462B2Material and methods for treating or preventing HER-3 associated diseasesDAIICHI SANKYO EUROPE GMBH·Filed 2016·Granted Jun 5, 2018·2 cites·31 claims
- 1078US9284379B2FGFR4 antibodiesU3 PHARMA GMBH·Filed 2013·Granted Mar 15, 2016·2 cites·18 claims
- 1178US9249230B2Antibodies directed to HER-3 and uses thereofROTHE MIKE·Filed 2009·Granted Feb 2, 2016·2 cites·62 claims
- 1278US5670319AAssay for tumor necrosis factor receptor-associated factorsGENENTECH INC·Filed 1994·Granted Sep 23, 1997·26 cites·8 claims
- 1376US8933202B2AXL antibodiesHETTMANN THORE·Filed 2008·Granted Jan 13, 2015·7 cites·28 claims
- 1475US7910100B2Antibodies directed to the mammalian EAG1 ion channel proteinMAX PLANCK GESELLSCHAFT·Filed 2005·Granted Mar 22, 2011·7 cites·15 claims
- 1573US10941198B2Human anti-IFN-α antibodiesIMMUNOQURE AG·Filed 2018·Granted Mar 9, 2021·1 cites·30 claims
- 1670US11267900B2Antibodies directed to HER-3 and uses thereofDAIICHI SANKYO EUROPE GMBH·Filed 2018·Granted Mar 8, 2022·0 cites·12 claims
- 1769US6235513B1IKK-α proteins, nucleic acids and methodsTULARIK INC·Filed 1998·Granted May 22, 2001·20 cites·36 claims
- 1868US11945861B2Human anti-IFN-α antibodiesIMMUNOQURE AG·Filed 2021·Granted Apr 2, 2024·0 cites·23 claims
- 1968US7754858B2Antibodies to tumor necrosis factor receptor associated factor polypeptidesGENENTECH INC·Filed 2007·Granted Jul 13, 2010·0 cites·2 claims
- 2065US7244836B2Tumor necrosis factor receptor-associated factorsGENENTECH INC·Filed 2002·Granted Jul 17, 2007·0 cites·15 claims
- 2165US6235512B1IKK-α proteins, nucleic acids and methodsTULARIK INC·Filed 1997·Granted May 22, 2001·13 cites·17 claims
- 2265US2004087774A1TRAF inhibitorsGENENTECH INC·Filed 2003·Application pending·0 cites
- 2364US5869612ATumor necrosis factor receptor-associated factorsGENENTECH INC·Filed 1996·Granted Feb 9, 1999·8 cites·5 claims
- 2463US5843721ANucleic acids encoding human NIK proteinTULARIK INC·Filed 1997·Granted Dec 1, 1998·19 cites·15 claims
- 2562US5708142ATumor necrosis factor receptor-associated factorsGENENTECH INC·Filed 1994·Granted Jan 13, 1998·17 cites·1 claims
- 2661US5741667ATumor necrosis factor receptor-associated factorsGENENTECH INC·Filed 1995·Granted Apr 21, 1998·16 cites·6 claims
- 2760US5844073AHuman NIK proteinsTULARIK INC·Filed 1998·Granted Dec 1, 1998·16 cites·6 claims
- 2860US2006019365A1IKK-alpha proteins, nucleic acids and methodsAMGEN INC·Filed 2005·Application pending·0 cites
- 2959US10100124B2Antibodies directed to HER-3 and uses thereofAMGEN INC·Filed 2015·Granted Oct 16, 2018·0 cites·18 claims
- 3059US6964765B2Inhibitors of apoptosisAMGEN INC·Filed 2004·Granted Nov 15, 2005·1 cites·6 claims
- 3158US8394927B2FGFR4 antibodiesBANGE JOHANNES·Filed 2007·Granted Mar 12, 2013·1 cites·15 claims
- 3257US8828382B2Heparin-binding epidermal growth factor-like growth factor binding proteinsROTHE MIKE·Filed 2008·Granted Sep 9, 2014·0 cites·10 claims
- 3355US2010047829A1Activated her3 as a marker for predicting therapeutic efficacyU3 PHARMA GMBH·Filed 2007·Application pending·0 cites
- 3454US10975144B2CDNA encoding a monoclonal anti-IL-32 antibody and methods for the production of the antibodyIMMUNOQURE AG·Filed 2018·Granted Apr 13, 2021·0 cites·20 claims
- 3554US6479266B1IKK-α proteins nucleic acids and methodsTULARIK INC·Filed 1998·Granted Nov 12, 2002·10 cites·20 claims
- 3653US5639858AHuman signal transducer and binding assaysTULARIK INC·Filed 1995·Granted Jun 17, 1997·12 cites·40 claims
- 3752US6235492B1IKK-α proteins, nucleic acids and methodsTULARIK INC·Filed 1998·Granted May 22, 2001·10 cites·49 claims
- 3851US6855815B2Inhibitors of apoptosisAMGEN INC·Filed 2002·Granted Feb 15, 2005·0 cites·5 claims
- 3951US6821736B1Inhibitors of apoptosisAMGEN INC·Filed 2000·Granted Nov 23, 2004·0 cites·6 claims
- 4050US7045613B2IKK-αproteins, nucleic acids and methodsAMGEN INC·Filed 2002·Granted May 16, 2006·0 cites·20 claims
- 4148US6294348B1TRAF inhibitorsGENENTECH INC·Filed 1998·Granted Sep 25, 2001·6 cites·6 claims
- 4246US6060303ATRAF inhibitorsGENENTECH INC·Filed 1998·Granted May 9, 2000·2 cites·12 claims
- 4345US10365283B2Activated HER3 as a marker for predicting therapeutic efficacyU3 PHARMA GMBH·Filed 2016·Granted Jul 30, 2019·0 cites·9 claims
- 4445US6500922B1Tumor necrosis factor receptor-associated factorsGENENTECH INC·Filed 1997·Granted Dec 31, 2002·4 cites·3 claims
- 4545US2015152193A1Axl antibodiesU3 PHARMA GMBH·Filed 2014·Application pending·0 cites
- 4644US5874230AAssays using TRAF2-associated protein kinase polypeptidesTULARIK INC·Filed 1996·Granted Feb 23, 1999·3 cites·17 claims
- 4743US5756700ANucleic acid encoding human signal transducer and activator of transcription 4TULARIK INC·Filed 1997·Granted May 26, 1998·5 cites·40 claims
- 4839US6063585ATRAF InhibitorsGENENTECH INC·Filed 1998·Granted May 16, 2000·2 cites·7 claims
- 4938US6004553ATRAF inhibitorsGENENTECH INC·Filed 1998·Granted Dec 21, 1999·1 cites·4 claims
- 5032US5981250ATRAF2-associated protein kinase and assaysTULARIK INC·Filed 1999·Granted Nov 9, 1999·0 cites·6 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mike Rothe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →